549PIMPACT OF TUMOUR RAS/BRAF STATUS ON EFFICACY OF FIRST-LINE PANITUMUMAB + FOLFIRI IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC).
暂无分享,去创建一个
R. Greil | C. Köhne | R. Hofheinz | L. Mineur | K. Oliner | M. Karthaus | J. Thaler | E. Fernebro | F. Overkamp | H. Kröning | J. Terwey